Outcomes in highly sensitized pediatric heart transplant patients using current management strategies Alfred Asante-Korang, MD, Ernest K. Amankwah, PhD, Mayra Lopez-Cepero, PhD, Jeremy Ringewald, MD, Jennifer Carapellucci, BSN, Diane Krasnopero, DNP, Alex Berg, ARNP, James Quintessenza, MD, Jeffrey P. Jacobs, MD The Journal of Heart and Lung Transplantation Volume 34, Issue 2, Pages 175-181 (February 2015) DOI: 10.1016/j.healun.2014.09.027 Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions
Figure 1 Individual reductions in percent PRA before and after desensitization (p < 0.0001). The Journal of Heart and Lung Transplantation 2015 34, 175-181DOI: (10.1016/j.healun.2014.09.027) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions
Figure 2 Kaplan–Meier survival plot comparing sensitized patients with non-sensitized patients after 2005. Log-rank test shows no statistically significant difference between the two curves (p < 0.28). The Journal of Heart and Lung Transplantation 2015 34, 175-181DOI: (10.1016/j.healun.2014.09.027) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions
Figure 3 Kaplan–Meier survival plot comparing sensitized patients with non-sensitized patients before 2005. Log-rank test shows a statistically significant difference between the two curves (p < 0.046). The Journal of Heart and Lung Transplantation 2015 34, 175-181DOI: (10.1016/j.healun.2014.09.027) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions